MX2018002193A - Metodo de uso de quinoxalinilo-piperazinamida. - Google Patents
Metodo de uso de quinoxalinilo-piperazinamida.Info
- Publication number
- MX2018002193A MX2018002193A MX2018002193A MX2018002193A MX2018002193A MX 2018002193 A MX2018002193 A MX 2018002193A MX 2018002193 A MX2018002193 A MX 2018002193A MX 2018002193 A MX2018002193 A MX 2018002193A MX 2018002193 A MX2018002193 A MX 2018002193A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- piperazinamide
- quinoxalinyl
- kits
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Abstract
La materia descrita provee métodos que usan y kits que comprenden un compuesto de la fórmula (I) (ver Fórmula) o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562214678P | 2015-09-04 | 2015-09-04 | |
US201662289820P | 2016-02-01 | 2016-02-01 | |
PCT/US2016/050172 WO2017040980A2 (en) | 2015-09-04 | 2016-09-02 | Quinoxalinyl-piperazinamide methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018002193A true MX2018002193A (es) | 2018-08-01 |
Family
ID=56896854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018002193A MX2018002193A (es) | 2015-09-04 | 2016-09-02 | Metodo de uso de quinoxalinilo-piperazinamida. |
Country Status (9)
Country | Link |
---|---|
US (3) | US9969698B2 (es) |
EP (1) | EP3344250A2 (es) |
JP (1) | JP2018526392A (es) |
KR (1) | KR20180049015A (es) |
CN (1) | CN108025009A (es) |
AU (1) | AU2016316056A1 (es) |
CA (1) | CA2994184A1 (es) |
MX (1) | MX2018002193A (es) |
WO (1) | WO2017040980A2 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS567710A (en) | 1979-06-28 | 1981-01-27 | Sansho Seiyaku Kk | Whitening cosmetic |
EP0188040B1 (en) | 1985-01-11 | 1991-08-14 | Abbott Laboratories Limited | Slow release solid preparation |
JP2773959B2 (ja) | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
CN1163223C (zh) | 1998-07-28 | 2004-08-25 | 田边制药株式会社 | 肠内目标部位释放型制剂 |
DE602005026557D1 (de) | 2004-11-17 | 2011-04-07 | Korea Res Inst Chem Tech | 1-ä(6-substituiertes alkoxychinoxalinyl) aminocarbonylü-4-(hetero)arylpiperazinderivate |
PT2785375T (pt) | 2011-11-28 | 2020-10-29 | Merck Patent Gmbh | Anticorpos anti-pd-l1 e usos destes |
JP6063090B2 (ja) | 2013-06-28 | 2017-01-18 | レクサン ファーマシューティカルズ インコーポレイテッド | ナノ粒子状組成物およびピペラジン化合物の製剤 |
-
2016
- 2016-09-02 WO PCT/US2016/050172 patent/WO2017040980A2/en active Application Filing
- 2016-09-02 AU AU2016316056A patent/AU2016316056A1/en not_active Abandoned
- 2016-09-02 CN CN201680049569.4A patent/CN108025009A/zh active Pending
- 2016-09-02 MX MX2018002193A patent/MX2018002193A/es unknown
- 2016-09-02 KR KR1020187009465A patent/KR20180049015A/ko unknown
- 2016-09-02 JP JP2018511753A patent/JP2018526392A/ja active Pending
- 2016-09-02 EP EP16763710.7A patent/EP3344250A2/en not_active Withdrawn
- 2016-09-02 CA CA2994184A patent/CA2994184A1/en not_active Abandoned
- 2016-09-02 US US15/255,910 patent/US9969698B2/en not_active Expired - Fee Related
-
2018
- 2018-04-06 US US15/946,955 patent/US10570101B2/en not_active Expired - Fee Related
-
2020
- 2020-01-21 US US16/748,440 patent/US20200231553A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN108025009A (zh) | 2018-05-11 |
WO2017040980A2 (en) | 2017-03-09 |
WO2017040980A3 (en) | 2017-05-11 |
KR20180049015A (ko) | 2018-05-10 |
US10570101B2 (en) | 2020-02-25 |
US20200231553A1 (en) | 2020-07-23 |
CA2994184A1 (en) | 2017-03-09 |
US20180290985A1 (en) | 2018-10-11 |
US9969698B2 (en) | 2018-05-15 |
EP3344250A2 (en) | 2018-07-11 |
AU2016316056A1 (en) | 2018-02-01 |
US20170066726A1 (en) | 2017-03-09 |
JP2018526392A (ja) | 2018-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
MX2021003311A (es) | Sondas para la proyeccion de imagen de la proteina huntingtina. | |
MA39749A (fr) | Dérivés de pipéridine-dione | |
PH12017501523A1 (en) | Selective bace1 inhibitors | |
TW201613872A (en) | IRAK4 inhibiting agents | |
PH12019501022A1 (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
MX2021005891A (es) | Sondas para la proyeccion de imagen de la proteina huntingtina. | |
PH12016501252A1 (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
MX2017002702A (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
SA517381678B1 (ar) | مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي | |
MX2017002705A (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
MY186475A (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia | |
PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
JOP20190163B1 (ar) | منشط nrf2 | |
AU2016330503A8 (en) | Therapeutic compounds and methods of use thereof | |
MX2019010640A (es) | Formas cristalinas de acido obeticolico. | |
MX2019005504A (es) | Potenciadores de bmp. | |
MX2018002193A (es) | Metodo de uso de quinoxalinilo-piperazinamida. | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
UA100342U (ru) | Применение натриевой соли гидрогенсульфида как средства для снижения гастротоксичности нестероидных противовоспалительных средств |